Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10. Clinical Medicine and Pharmacology, [S. l.], v. 2, n. 1, 2025. DOI: 10.70731/rek12e38. Disponível em: https://press.jandoo.ac/journal/cmp/article/view/232. Acesso em: 14 jul. 2025.